Skip to main content
. 2018 Sep 20;46(19):10195–10215. doi: 10.1093/nar/gky804

Figure 2.

Figure 2.

BCL2 or MCL1 is inferior to BCL-XL in promoting iPSC survival and editing efficiency. (A and B) Effects of BCL2 and MCL1 on human iPSC survival and editing. Cell survival was determined by cell count on day 1 after electroporation. KI or KO efficiency was determined on day 3 or 7 by FACS; n = 4–5. (C) Relative expression of Cas9 and sgRNA by RT-qPCR; n = 6. RT-qPCR analysis was conducted 8 hours after electroporation; *P < 0.05; **P < 0.01; ***P < 0.001; ns = not significant.